Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predictive biochemical assays for late radiation effects.

P Rubin, J N Finkelstein, D W Siemann

    International Journal of Radiation Oncology, Biology, Physics
    |April 1, 1986
    PubMed
    Summary

    Type II pneumocytes release surfactant after radiation, serving as an early biochemical marker for lung damage. This finding aids in predicting radiation pneumonitis and fibrosis, crucial in combined cancer therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Therapeutic Modification of Hypoxia.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2021
    Same author

    Realizing the Potential of Vascular Targeted Therapy: The Rationale for Combining Vascular Disrupting Agents and Anti-Angiogenic Agents to Treat Cancer.

    Cancer investigation·2017
    Same author

    Comments on the history of the Biological Stain Commission, Inc.

    Biotechnic & histochemistry : official publication of the Biological Stain Commission·2011
    Same author

    Pulmonary injury after combined exposures to low-dose low-LET radiation and fungal spores.

    Radiation research·2011
    Same author

    Stain and dye stability over a 30-year period: a comparison of certified dye powders by the Biological Stain Commission.

    Biotechnic & histochemistry : official publication of the Biological Stain Commission·2008
    Same author

    Revised procedures for the certification of carmine (C.I. 75470, Natural red 4) as a biological stain.

    Biotechnic & histochemistry : official publication of the Biological Stain Commission·2007

    Area of Science:

    • Pulmonary Medicine
    • Radiation Oncology
    • Biochemistry

    Background:

    • Combined modality cancer therapy often causes pneumonitis and pulmonary fibrosis.
    • Type II pneumocytes are implicated in the pathophysiology of radiation-induced lung injury.
    • Identifying early biochemical markers is crucial for predicting late radiation effects.

    Purpose of the Study:

    • To investigate Type II pneumocytes as early biochemical markers for late radiation effects.
    • To understand the role of Type II pneumocytes in radiation pneumonitis and fibrosis.
    • To establish a correlation between early surfactant release and later lethality.

    Main Methods:

    • Ultrastructural and biochemical analysis of Type II pneumocytes.
    • In vivo studies using lavaging techniques in murine strains and rabbits.

    Related Experiment Videos

  • In vitro studies using cultured Type II pneumocytes.
  • Histological and electron microscopy techniques.

    • Main Results:

    • Type II pneumocytes are an early target of radiation, with persistent surfactant release post-exposure.
    • Elevated alveolar surfactant levels were observed after pulmonary irradiation.
    • A strong correlation exists between early surfactant release (7/28 days) and later lethality in animal models.
    • In vitro studies confirmed dose-response and tolerance factors comparable to in vivo models.

    Conclusions:

    • Surfactant precursors from Type II pneumocytes show potential as early biochemical markers for late radiation effects.
    • These findings are clinically significant for managing pneumonitis and fibrosis in cancer patients.
    • Further development of these markers could lead to predictive indices for radiation-induced lung damage.